Serna Bio
Genetic Medicine with Small Molecules
Ontario, United States · Founded 2021 · $500K raised
- Headquarters
- Ontario, California
- Employees
- 1–10
- Founded
- 2021
- Website
- serna.bio
- Total Funding
- $500K
- Last Round
- $500K SeedJan 2021
- Rounds
- 1
About
Serna Bio is developing small molecules to modulate RNA function, unlocking the potential to treat diseases driven by biology intractable by other modalities.
Summary
Serna Bio is a Biotech company based in Ontario, United States, founded in 2021. It has raised $500K in total across 1 round, most recently a $500K Seed round in Jan 2021. Investors include Y Combinator Continuity Fund, Amino Collective and Lifeforce Capital.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2021
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.